Clinical Trial

PrEP4Her: Developing a Novel Strategy to Implement PrEP Into Women's Healthcare

Completed
View on ClinicalTrials.gov →
Summary
The purpose of the study is to learn more about health care providers' experiences and perspectives on prescribing HIV pre-exposure prophylaxis, also known as PrEP. Providers and patients in gynecology clinics were interviewed and completed surveys to measure the feasibility and preference of prescribing PrEP.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-29.
Trial Details
NCT Number NCT07209722
Lead Sponsor University of Alabama at Birmingham
Collaborators: National Institute of Mental Health (NIMH)
Conditions PrEP Precriptions for Reproductive Aged Women
Enrollment 1,377 participants
Start Date 2023-09-22
Primary Completion 2025-08-16 (estimated)
Study Completion 2025-08-16 (estimated)
Updated on ClinicalTrials.gov 2026-01-26